Position in ICLR
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,442,758
+$3,206,872 QoQ
Shares Held
19,819
+1370.3% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#145
of 422 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $38,856,052 across 14 Diagnostics & Research names. ICLR ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
32,040 | $16,063,574 | |
| 2 | DHR |
Danaher Corp /De/
|
36,041 | $6,865,089 | |
| 3 | WAT |
Waters Corp /De/
|
11,672 | $4,377,466 | |
| 4 | ICLR |
Icon PLC
This page
|
19,819 | $3,442,758 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
5,873 | $3,091,782 | |
| 6 | DGX |
Quest Diagnostics Inc
|
6,572 | $1,392,935 | |
| 7 | A |
Agilent Technologies, Inc.
|
7,622 | $1,012,430 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,859 | $520,520 |
All Filings in ICLR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,442,758 | 19,819 | Shares | Sole | 2026-07-23 | |
| 2025-03-31 | $235,886 | 1,348 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $281,851 | 981 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $319,739 | 1,020 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $376,935 | 1,122 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $335,154 | 1,184 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||